HomeGWLL • OTCMKTS
add
Goldenwell Biotech Inc
Previous close
$0.20
Year range
$0.15 - $0.33
Market cap
19.80M USD
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 23.06K | -35.20% |
Net income | -23.06K | 34.86% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.76K | -60.11% |
Total assets | 179.43K | -4.01% |
Total liabilities | 198.67K | 144.04% |
Total equity | -19.24K | — |
Shares outstanding | 99.00M | — |
Price to book | ∞ | — |
Return on assets | -30.36% | — |
Return on capital | 748.30% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -23.06K | 34.86% |
Cash from operations | -23.06K | 34.49% |
Cash from investing | — | — |
Cash from financing | 2.10K | -93.00% |
Net change in cash | -20.96K | -302.40% |
Free cash flow | -14.42K | 34.27% |
About
Founded
2019
Headquarters
Website
